The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism

Murat Oz, Vanaja Jaligam, Sehamuddin Galadari, George Petroianu, Yaroslav M. Shuba, Toni S. Shippenberg

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds